153 related articles for article (PubMed ID: 37815913)
1. Dose planning study of proton versus photon radiotherapy for head and neck squamous cell carcinoma of unknown primary in the primary and recurrent setting.
Holm AIS; Elstrøm UV; Nielsen SB; Jensen K
Acta Oncol; 2023 Nov; 62(11):1412-1417. PubMed ID: 37815913
[TBL] [Abstract][Full Text] [Related]
2. Benefit of particle therapy in re-irradiation of head and neck patients. Results of a multicentric in silico ROCOCO trial.
Eekers DBP; Roelofs E; Jelen U; Kirk M; Granzier M; Ammazzalorso F; Ahn PH; Janssens GORJ; Hoebers FJP; Friedmann T; Solberg T; Walsh S; Troost EGC; Kaanders JHAM; Lambin P
Radiother Oncol; 2016 Dec; 121(3):387-394. PubMed ID: 27639891
[TBL] [Abstract][Full Text] [Related]
3. Radiation dose-painting with protons vs. photons for head-and-neck cancer.
Håkansson K; Smulders B; Specht L; Zhu M; Friborg J; Rasmussen JH; Bentzen SM; Vogelius IR
Acta Oncol; 2020 May; 59(5):525-533. PubMed ID: 31964199
[No Abstract] [Full Text] [Related]
4. Dosimetric comparison of protons vs photons in re-irradiation of intracranial meningioma.
Poel R; Stuessi Lobmaier A; Andratschke N; Unkelbach J; Tanadini-Lang S; Guckenberger M; Foerster R
Br J Radiol; 2019 Aug; 92(1100):20190113. PubMed ID: 31264474
[TBL] [Abstract][Full Text] [Related]
5. Photons or protons for reirradiation in (non-)small cell lung cancer: Results of the multicentric ROCOCO
Troost EGC; Wink KCJ; Roelofs E; Simone CB; Makocki S; Löck S; van Kollenburg P; Dechambre D; Minken AWH; van der Stoep J; Avery S; Jansen N; Solberg T; Bussink J; de Ruysscher D
Br J Radiol; 2020 Mar; 93(1107):20190879. PubMed ID: 31804145
[TBL] [Abstract][Full Text] [Related]
6. Considerations for study design in the DAHANCA 35 trial of protons versus photons for head and neck cancer.
Friborg J; Jensen K; Eriksen JG; Samsøe E; Maare C; Farhadi M; Sibolt P; Nielsen M; Andersen M; Holm AIS; Skyt P; Smulders B; Johansen J; Overgaard J; Grau C; Hansen CR
Radiother Oncol; 2024 Jan; 190():109958. PubMed ID: 37871751
[TBL] [Abstract][Full Text] [Related]
7. NTCP reduction for advanced head and neck cancer patients using proton therapy for complete or sequential boost treatment versus photon therapy.
Jakobi A; Stützer K; Bandurska-Luque A; Löck S; Haase R; Wack LJ; Mönnich D; Thorwarth D; Perez D; Lühr A; Zips D; Krause M; Baumann M; Perrin R; Richter C
Acta Oncol; 2015; 54(9):1658-64. PubMed ID: 26340301
[TBL] [Abstract][Full Text] [Related]
8. Comparison of organ-at-risk sparing and plan robustness for spot-scanning proton therapy and volumetric modulated arc photon therapy in head-and-neck cancer.
Barten DL; Tol JP; Dahele M; Slotman BJ; Verbakel WF
Med Phys; 2015 Nov; 42(11):6589-98. PubMed ID: 26520750
[TBL] [Abstract][Full Text] [Related]
9. [Proton therapy for head and neck squamous cell carcinomas: From physics to clinic].
Beddok A; Vela A; Calugaru V; Tessonnier T; Kubes J; Dutheil P; Gérard A; Vidal M; Goudjil F; Florescu C; Kammerer E; Bénézery K; Hérault J; Bourhis J; Thariat J;
Cancer Radiother; 2019 Sep; 23(5):439-448. PubMed ID: 31358445
[TBL] [Abstract][Full Text] [Related]
10. Unknown primary head and neck cancer treated with intensity-modulated radiation therapy: to what extent the volume should be irradiated.
Lu H; Yao M; Tan H
Oral Oncol; 2009 Jun; 45(6):474-9. PubMed ID: 18804408
[TBL] [Abstract][Full Text] [Related]
11. Total Mucosal Irradiation with Intensity-modulated Radiotherapy in Patients with Head and Neck Carcinoma of Unknown Primary: A Pooled Analysis of Two Prospective Studies.
Richards TM; Bhide SA; Miah AB; Del Rosario L; Bodla S; Thway K; Gujral DM; Rooney KP; Schick U; McGovern T; Grove L; Newbold KL; Harrington KJ; Nutting CM
Clin Oncol (R Coll Radiol); 2016 Sep; 28(9):e77-e84. PubMed ID: 27180092
[TBL] [Abstract][Full Text] [Related]
12. Low contralateral failure rate with unilateral proton beam radiotherapy for oropharyngeal squamous cell carcinoma: A multi-institutional prospective study from the proton collaborative group.
Mumaw DA; Hazy AJ; Vayntraub A; Quinn TJ; Salari K; Chang JH; Kalman N; Katz S; Urbanic J; Press RH; Thukral AD; Tsai H; Laramore GE; Molitoris J; Vargas C; Patel SH; Stevens C; Deraniyagala RL
Radiother Oncol; 2024 Jan; 190():109977. PubMed ID: 37922991
[TBL] [Abstract][Full Text] [Related]
13. A treatment planning comparison of 3D conformal therapy, intensity modulated photon therapy and proton therapy for treatment of advanced head and neck tumours.
Cozzi L; Fogliata A; Lomax A; Bolsi A
Radiother Oncol; 2001 Dec; 61(3):287-97. PubMed ID: 11730999
[TBL] [Abstract][Full Text] [Related]
14. Automated Robust Proton Planning Using Dose-Volume Histogram-Based Mimicking of the Photon Reference Dose and Reducing Organ at Risk Dose Optimization.
Kierkels RGJ; Fredriksson A; Both S; Langendijk JA; Scandurra D; Korevaar EW
Int J Radiat Oncol Biol Phys; 2019 Jan; 103(1):251-258. PubMed ID: 30145392
[TBL] [Abstract][Full Text] [Related]
15. Comparing the quality of passively-scattered proton and photon tomotherapy plans for brain and head and neck disease sites.
Kainz K; Firat S; Wilson JF; Schultz C; Siker M; Wang A; Olson D; Li XA
Phys Med Biol; 2015 Mar; 60(6):2167-77. PubMed ID: 25683607
[TBL] [Abstract][Full Text] [Related]
16. Dosimetric comparison between VMAT with different dose calculation algorithms and protons for soft-tissue sarcoma radiotherapy.
Fogliata A; Scorsetti M; Navarria P; Catalano M; Clivio A; Cozzi L; Lobefalo F; Nicolini G; Palumbo V; Pellegrini C; Reggiori G; Roggio A; Vanetti E; Alongi F; Pentimalli S; Mancosu P
Acta Oncol; 2013 Apr; 52(3):545-52. PubMed ID: 22671576
[TBL] [Abstract][Full Text] [Related]
17. HYpofractionated, dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase I HYDRA trial.
Elbers JBW; Gunsch PA; Debets R; Keereweer S; van Meerten E; Zindler J; van Norden Y; Hoogeman MS; Verduijn GM; Kroesen M; Nout RA
BMC Cancer; 2023 Jun; 23(1):541. PubMed ID: 37312053
[TBL] [Abstract][Full Text] [Related]
18. Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer.
Moreno AC; Frank SJ; Garden AS; Rosenthal DI; Fuller CD; Gunn GB; Reddy JP; Morrison WH; Williamson TD; Holliday EB; Phan J; Blanchard P
Oral Oncol; 2019 Jan; 88():66-74. PubMed ID: 30616799
[TBL] [Abstract][Full Text] [Related]
19. SPECT/CT-guided elective nodal irradiation for head and neck cancer: Estimation of clinical benefits using NTCP models.
de Veij Mestdagh PD; Janssen T; Lamers E; Carbaat C; Hamming-Vrieze O; Vogel WV; Sonke JJ; Al-Mamgani A
Radiother Oncol; 2019 Jan; 130():18-24. PubMed ID: 30087057
[TBL] [Abstract][Full Text] [Related]
20. Spot scanning proton arc therapy reduces toxicity in oropharyngeal cancer patients.
de Jong BA; Battinelli C; Free J; Wagenaar D; Engwall E; Janssens G; Langendijk JA; Korevaar EW; Both S
Med Phys; 2023 Mar; 50(3):1305-1317. PubMed ID: 36373893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
